Glioblastoma: Part I. Current state of affairs
- PMID: 21736079
- PMCID: PMC6188294
Glioblastoma: Part I. Current state of affairs
Abstract
Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future.
Figures






Similar articles
-
Glioblastoma. Part II: Future directions.Mo Med. 2011 Jul-Aug;108(4):289-91. Mo Med. 2011. PMID: 21905448 Free PMC article. Review.
-
Glioblastoma multiforme: evidence-based approach to therapy.Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S23-7. doi: 10.1586/14737140.7.12s.S23. Expert Rev Anticancer Ther. 2007. PMID: 18076314 Review.
-
Recent and ongoing clinical trials in glioblastoma.Clin Adv Hematol Oncol. 2018 Jul;16(7):480-483. Clin Adv Hematol Oncol. 2018. PMID: 30067618 No abstract available.
-
Does gender matter in glioblastoma?Clin Transl Oncol. 2011 Oct;13(10):737-41. doi: 10.1007/s12094-011-0725-7. Clin Transl Oncol. 2011. PMID: 21975336
-
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.Acta Neurochir (Wien). 2007 Mar;149(3):245-52; discussion 252-3. doi: 10.1007/s00701-006-1092-y. Epub 2007 Feb 2. Acta Neurochir (Wien). 2007. PMID: 17273889
Cited by
-
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.J Transl Med. 2014 Jan 17;12:13. doi: 10.1186/1479-5876-12-13. J Transl Med. 2014. PMID: 24433351 Free PMC article.
-
Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.Xenobiotica. 2012 Aug;42(8):748-55. doi: 10.3109/00498254.2012.662726. Epub 2012 Mar 8. Xenobiotica. 2012. PMID: 22401348 Free PMC article.
-
BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.Cell Death Dis. 2012 Oct 18;3(10):e412. doi: 10.1038/cddis.2012.153. Cell Death Dis. 2012. PMID: 23076220 Free PMC article.
-
Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging.Biomed Rep. 2023 Sep 22;19(5):82. doi: 10.3892/br.2023.1664. eCollection 2023 Nov. Biomed Rep. 2023. PMID: 37881606 Free PMC article.
-
Glioblastoma: Overview of Disease and Treatment.Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8. doi: 10.1188/16.CJON.S1.2-8. Clin J Oncol Nurs. 2016. PMID: 27668386 Free PMC article. Review.
References
-
- CBTRUS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004–2006. Source Central Brain Tumor Registry of the United States; Hinsdale, IL: 2010. website: www.cbtrus.org.
-
- American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009.
-
- Myung SK, Ju W, McDonnell DD, et al. Mobile Phone Use and the Risk of Tumors: A Meta-Analysis. Journal Clinical Oncology. 2009 Nov 20;27(33):5565–72. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical